Skip to main content

Market Overview

70 Biggest Movers From Yesterday

Share:

Gainers

  • Forward Pharma A/S (NASDAQ: FWP) shares gained 69.9% to close at $9.60 on Wednesday.
  • Camber Energy, Inc. (NYSE: CEI) shares climbed 69.4% to close at $2.05 on Wednesday. The stock rallied more than 60% Tuesday to close over the $1 level. About 7.2 million shares traded Tuesday, compared to average daily volume of just 2.3 million shares.
  • Marinus Pharmaceuticals Inc (NASDAQ: MRNS) rose 38% to close at $1.78 despite pricing its common stock offering of 28 million shares at $1.25 per share.
  • XP Inc. (NASDAQ: XP) rose 27.6% to close at $34.46.
  • Immunic, Inc. (NASDAQ: IMUX) jumped 24.6% to close at $8.96.
  • Centogene N.V. (NASDAQ: CNTG) rose 23.8% to close at $11.20.
  • Abeona Therapeutics Inc. (NASDAQ: ABEO) gained 22.6% to close at $4.02.
  • Photronics, Inc. (NASDAQ: PLAB) rose 20.4% to close at $15.13 after the company reported better-than-expected Q4 sales results. The company also issued Q1 EPS and sales guidance above analyst estimates.
  • Aptose Biosciences Inc. (NASDAQ: APTO) gained 17.6% to close at $4.41.
  • Cohen & Company Inc. (NYSE: COHN) rose 17.1% to close at $3.50.
  • AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX) gained 16.9% to close at $2.3850.
  • Dermira, Inc. (NASDAQ: DERM) rose 16.6% to close at $11.67 on continued momentum after the company received Fast Track destination for Lebrikizumab for the treatment of atopic dermatitis.
  • Aprea Therapeutics, Inc. (NASDAQ: APRE) gained 16.3% to close at $35.70.
  • Trans World Entertainment Corporation (NASDAQ: TWMC) rose 15.7% to close at $3.32.
  • Ollie's Bargain Outlet Holdings Inc (NASDAQ: OLLI) climbed 15% to close at $69.33 after reporting a third-quarter earnings beat.
  • Plus Therapeutics, Inc. (NASDAQ: PSTV) gained 13.3% to close at $2.39.
  • Ranpak Holdings Corp (NYSE: PACK) rose 12.4% to close at $6.60. Ranpak priced 15.4 million share common stock offering at $6.50 per share.
  • BioNTech SE (NASDAQ: BNTX) gained 11.8% to close at $31.30.
  • Danaos Corporation (NYSE: DAC) rose 10.9% to close at $8.44.
  • SCWorx Corp. (NASDAQ: WORX) gained 10.7% to close at $3.20.
  • Daseke, Inc. (NASDAQ: DSKE) jumped 10.7% to close at $3.32.
  • Hebron Technology Co., Ltd. (NASDAQ: HEBT) shares gained 10.5% to close at $8.60.
  • LMP Automotive Holdings, Inc. (NASDAQ: LMPX) rose 10.5% to close at $15.38.
  • Rekor Systems, Inc. (NASDAQ: REKR) surged 10.4% to close at $3.40.
  • Five Prime Therapeutics, Inc. (NASDAQ: FPRX) shares rose 10.4% to close at $4.5150.
  • Neovasc Inc. (NASDAQ: NVCN) surged 10.4% to close at $3.29.
  • Sorrento Therapeutics, Inc. (NASDAQ: SRNE) rose 10.2% to close at $4.16.
  • Sibanye Gold Limited (NYSE: SBGL) jumped 9.8% to close at $9.33.
  • Cerecor Inc. (NASDAQ: CERC) gained 8.9% to close at $4.18.
  • Eastman Kodak Company (NYSE: KODK) rose 8.7% to close at $2.99.
  • Aspen Group Inc (NASDAQ: ASPU) shares rose 8.7% to close at $7.50 after the company reported better-than-expected Q2 EPS and sales results.
  • Sage Therapeutics, Inc. (NASDAQ: SAGE) gained 8.5% to close at $68.67.
  • Sibanye Gold Limited (NYSE: SBGL) shares rose 9.8% to close at $9.33.
  • 360 Finance, Inc. (NASDAQ: QFIN) rose 9% to close at $10.21.
  • MEDNAX, Inc. (NYSE: MD) climbed 8.1% to close at $26.78.
  • Yuma Energy, Inc. (NYSE: YUMA) shares gained 8.1% to close at $3.47.
  • LogMeIn, Inc. (NASDAQ: LOGM) rose 7.8% to close at $79.83 amid Bloomberg report that Francisco Partners and Elliott Associates are in talks to buy the company.
  • Proteostasis Therapeutics, Inc. (NASDAQ: PTI) gained 7.3% to close at $4.26 after the company announced ex-vivo results of its CFTR modulators in CF patients and said early results support the initiation of enrollment in its CHOICES trial.
  • Microbot Medical Inc. (NASDAQ: MBOT) shares gained 5.4% to close at $6.85.
  •  

Check out these big penny stock gainers and losers

Losers

  • Correvio Pharma Corp (NASDAQ: CORV) shares dipped 67.1% to close at $0.46 on Wednesday after the company announced plans to explore strategic alternatives. Correvio Pharma said FDA's Cardiovascular and Renal Advisory Committee, which reviewed its Brinavess, voted that the benefit-risk profile was not adequate to support approval, with two staffers voting for the drug and 11 against.
  • Iterum Therapeutics PLC (NASDAQ: ITRM) shares fell 35.7% to close at $3.12 after the company announced topline results from the Phase 3 clinical trial of oral and IV Sulopenem.
  • SG Blocks Inc (NASDAQ: SGBX) fell 31.9% to close at $0.15 after the company priced its public offering of 15 million shares at $0.15 per share.
  • United Natural Foods Inc. (NYSE: UNFI) dipped 28.4% to close at $7.07 after the company reported worse-than-expected Q1 EPS results. The company also issued FY20 EPS guidance below analyst estimates.
  • Technical Communications Corporation (NASDAQ: TCCO) fell 26.9% to close at $5.85 on Wednesday after jumping 321.05% on Tuesday.
  • Childrens Place Inc (NASDAQ: PLCE) fell 23.1% to close at $54.31 after the company reported worse-than-expected Q3 sales results. The company also issued Q4 EPS and sales guidance below analyst estimates.
  • Aethlon Medical, Inc. (NASDAQ: AEMD) dropped 16.8% to close at $2.4624.
  • Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) fell 16.4% to close at $99.08. Madrigal Pharmaceuticals said it has priced its previously-announced underwritten secondary offering of 1.2 million shares by investment funds affiliated with Bay Capital at $107.85 per share.
  • GameStop Corp. (NYSE: GME) shares fell 15.1% to close at $5.53 after the company reported worse-than-expected Q3 EPS and sales results. The company also cut FY19 adjusted EPS guidance from $1.15-$1.30 to $0.10-$0.20.
  • Relmada Therapeutics, Inc. (NASDAQ: RLMD) dropped 14.8% to close at $34.04.
  • Rocket Pharmaceuticals Inc (NASDAQ: RCKT) fell 14% to close at $20.84. Rocket Pharmaceuticals priced its 3.82 million share public offering of common stock at $22.25 per share.
  • Francesca's Holdings Corporation (NASDAQ: FRAN) declined 14% to close at $10.70 on continued momentum after the company reported Q3 EPS results down from last year and worse-than-expected Q3 sales results.
  • Venus Concept Inc. (NASDAQ: VERO) dropped 14% to close at $4.48.
  • SigmaTron International, Inc. (NASDAQ: SGMA) dipped 13.3% to close at $4.05 following Q2 results.
  • Momenta Pharmaceuticals, Inc. (NASDAQ: MNTA) fell 13.1% to close at $15.71 after the company reported a $200 million common stock offering.
  • Bat Group, Inc. (NASDAQ: GLG) shares fell 12.8% to close at $1.77.
  • Fluent, Inc. (NASDAQ: FLNT) dipped 12.7% to close at $2.06.
  • Impinj, Inc. (NASDAQ: PI) dropped 12.1% to close at $27.10.
  • Surface Oncology, Inc. (NASDAQ: SURF) shares declined 11.1% to close at $1.84.
  • Atreca, Inc. (NASDAQ: BCEL) dropped 10.3% to close at $13.71.
  • Artelo Biosciences, Inc. (NASDAQ: ARTL) shares declined 10.2% to close at $2.20.
  • Safe-T Group Ltd (NASDAQ: SFET) fell 9.9% to close at $3.92 after the company announced it has signed a partner agreement with a European affiliate of the Fortune 500 to resell Safe-T's products and solutions in Spain, Portugal and Israel.
  • Express, Inc. (NYSE: EXPR) dipped 9.8% to close at $5.55.
  • Columbus McKinnon Corporation (NASDAQ: CMCO) dropped 9.7% to close at $38.10 after the company announced the resignation of President, Director and CEO Mark Morelli.
  • Alteryx, Inc. (NYSE: AYX) dropped 8.6% to close at $98.41 potentially in anticipation of the company's presentation at Raymond James Technology Investors Conference.
  • Vera Bradley, Inc. (NASDAQ: VRA) dipped 8.3% to close at $11.03 following Q3 results.
  • KLX Energy Services Holdings, Inc. (NASDAQ: KLXE) tumbled 8% to close at $6.41.
  • Global Medical REIT Inc. (NYSE: GMRE) fell 8% to close at $13.00 after the company announced a 4.75 million share common stock offering.
  • Osmotica Pharmaceuticals plc (NASDAQ: OSMT) dropped 7.9% to close at $7.09.
  • EverQuote, Inc. (NASDAQ: EVER) fell 5.8% to close at $33.93.
  • Arcadia Biosciences, Inc. (NASDAQ: RKDA) dropped 5.3% to close at $5.55. Arcadia Biosciences Filing showed selling shareholders to offer 725.4k shares of stock.
 

Related Articles (ACRX + ABEO)

View Comments and Join the Discussion!

Posted-In: Movers From YesterdayNews Movers & Shakers Pre-Market Outlook Markets Movers Trading Ideas General

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com